These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4986625)

  • 1. [Oral antimycotic agent, 5-fluorocytosine].
    Scholer HJ
    Mykosen; 1970 Apr; 13(4):179-88. PubMed ID: 4986625
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-fluorocytosine in the treatment of mycotic infections.
    Vandevelde AG; Mauceri AA; Johnson JE
    Ann Intern Med; 1972 Jul; 77(1):43-51. PubMed ID: 4559539
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-fluorocytosine in the treatment of cryptococcal and candida mycoses.
    Fass RJ; Perkins RL
    Ann Intern Med; 1971 Apr; 74(4):535-9. PubMed ID: 5551162
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical results with a new antifungal agent.
    Neu HC
    Med Times; 1974 Feb; 102(2):75-7 passim. PubMed ID: 4810614
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy of cryptococcosis and chromomycosis using 5-fluorocytosine].
    González Ochoa A
    Rev Invest Salud Publica; 1970; 30(1):63-76. PubMed ID: 5433834
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-fluorocytosine: a replacement for amphotericin B in the treatment of candida and cryptococcus neoformans infections?
    Pankey GA; Lockwood WR; Montalvo JM
    J La State Med Soc; 1970 Dec; 122(12):365-9. PubMed ID: 5492591
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chromomycosis with 5-Fluorocytosine.
    Lopes CF; Cisalpino EO; Alvarenga RJ; Armond S; Pôrto RV; Maia FA; Peixoto Y
    Int J Dermatol; 1971; 10(3):182-91. PubMed ID: 5116172
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Polak A
    Chemotherapy; 1987; 33(5):381-95. PubMed ID: 2822362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with antifungal drugs.
    Polak A
    Mycoses; 1988; 31 Suppl 2():45-53. PubMed ID: 3067091
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
    Fortun Abete J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():4-14. PubMed ID: 9441305
    [No Abstract]   [Full Text] [Related]  

  • 11. Current therapy of pulmonary and disseminated fungal diseases.
    Stamm AM; Dismukes WE
    Chest; 1983 Jun; 83(6):911-7. PubMed ID: 6303713
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice.
    Polak A; Scholer HJ; Wall M
    Chemotherapy; 1982; 28(6):461-79. PubMed ID: 6297858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorocytosine--current status with special references to mode of action and drug resistance.
    Polak A
    Contrib Microbiol Immunol; 1977; 4():158-67. PubMed ID: 342192
    [No Abstract]   [Full Text] [Related]  

  • 14. Problems in the diagnosis and treatment of systemic candidiasis.
    Goldstein E; Hoeprich PD
    J Infect Dis; 1972 Feb; 125(2):190-3. PubMed ID: 5007556
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimycotic activity of BAY N 7133 in animal experiments.
    Plempel M
    J Antimicrob Chemother; 1984 May; 13(5):447-63. PubMed ID: 6330018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in antimycotic chemotherapy.
    Holt RJ
    Infection; 1974; 2(2):95-107. PubMed ID: 4601865
    [No Abstract]   [Full Text] [Related]  

  • 17. Cryptococcal meningitis: a case treated with 5-fluorocytosine.
    van den Ende EW; Hammond JA; Amoils RL
    S Afr Med J; 1974 Mar; 48(13):555-6. PubMed ID: 4823715
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chromomycosis. Visceral metastasizing type].
    Itani Z
    Dtsch Med Wochenschr; 1970 May; 95(20):1100-6. PubMed ID: 5445748
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience.
    Steer PL; Marks MI; Klite PD; Eickhoff TC
    Ann Intern Med; 1972 Jan; 76(1):15-22. PubMed ID: 5063168
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.
    Rabinovich S; Shaw BD; Bryant T; Donta ST
    J Infect Dis; 1974 Jul; 130(1):28-31. PubMed ID: 4601179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.